Search - tctmd.com

Displaying 381 - 400 of 853

Sort: Relevancy | Date

CHOICE: Intra-arterial tPA Enhances Benefit of Stroke Thrombectomy

News Conference News ISC 2022

CHOICE: Intra-arterial tPA Enhances Benefit of Stroke Thrombectomy

February 11, 2022

Chinese Herbal Formula Matches Losartan in Patients With Mild Hypertension

News Daily News

Chinese Herbal Formula Matches Losartan in Patients With Mild Hypertension

February 11, 2022

Segregation Linked to Hypertension Among Black, Hispanic Individuals

News Daily News

Segregation Linked to Hypertension Among Black, Hispanic Individuals

February 01, 2022

COVID-19: TCTMD’s Dispatch for February Week 1

News Daily News

COVID-19: TCTMD’s Dispatch for February Week 1

January 31, 2022

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

Yet Another US Report Shows Stalled Progress Against CHD

News Daily News

Yet Another US Report Shows Stalled Progress Against CHD

January 19, 2022

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

FDA Safety Communication Updates Stance on Endologix AAA Grafts

News Daily News

FDA Safety Communication Updates Stance on Endologix AAA Grafts

January 13, 2022

‘Home Time’ Validated as TAVI Outcomes Performance Metric

News Daily News

‘Home Time’ Validated as TAVI Outcomes Performance Metric

January 11, 2022

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

News Daily News

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

January 10, 2022

COVID-19: TCTMD’s Dispatch for January Week 2

News Daily News

COVID-19: TCTMD’s Dispatch for January Week 2

January 10, 2022

January 2022 News Roundup

News Opinion CV Team Dispatch

January 2022 News Roundup

January 01, 2022

TCTMD’s Top 10 Most Popular Stories for December 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for December 2021

December 29, 2021

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

December 28, 2021

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

News Daily News

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

December 27, 2021

FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels

News Daily News

FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels

Michael O'Riordan

December 22, 2021

Correction Issued for Controversial Study Linking COVID-19 Vaccines to ACS Risk

News Daily News

Correction Issued for Controversial Study Linking COVID-19 Vaccines to ACS Risk

December 22, 2021

COVID-19: TCTMD’s Dispatch for December Week 3

News Daily News

COVID-19: TCTMD’s Dispatch for December Week 3

December 20, 2021

British Medical Groups Express Concern About Inclisiran Rollout

News Daily News

British Medical Groups Express Concern About Inclisiran Rollout

Michael O'Riordan

December 14, 2021

COVID-19: TCTMD’s Dispatch for December Week 2

News Daily News

COVID-19: TCTMD’s Dispatch for December Week 2

December 13, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.